UK Tobacco and Vapes Bill to Ban Tobacco Sales to Those Born After 2009, Effective 2027

Nov.14.2024
UK Tobacco and Vapes Bill to Ban Tobacco Sales to Those Born After 2009, Effective 2027
The UK's Tobacco and Vapes Bill plans to gradually ban the sale of tobacco products to those born on or after January 1, 2009, and strengthen regulations on vapes and nicotine products, including introducing a licensing system and increasing fines for violations.

On November 13th, the UK government website released a document titled "Tobacco and Vapes Bill: creating a smoke-free UK and tackling youth vaping factsheet". This legislation will be a milestone in the UK's efforts to become a smoke-free nation.

 

The bill aims to gradually ban the sale of tobacco products and introduce a smoke-free generation nationwide. Selling tobacco products, herbal smoking products, and cigarette papers to individuals born on or after 1 January 2009 will be illegal. Children born on or after this date will never be able to be legally sold tobacco products, breaking the cycle of addiction and disadvantage.

 

The products in scope include:

 

 

  • cigarettes
  • hand rolled tobacco
  • cigars
  • cigarillos
  • pipe tobacco
  • waterpipe tobacco products (for example, shisha)
  • chewing tobacco
  • heated tobacco
  • nasal tobacco (snuff)
  • herbal smoking products
  • cigarette papers

 

 

Display, sales, and advertising restrictions:

 

 

In addition, the bill will also prohibit all vape and other nicotine products (such as nicotine pouches) from advertising and sponsorship, following strict restrictions similar to those imposed on tobacco.

 

The bill will fill a gap by banning the sale of all vapes and nicotine products to those under 18 years old, as well as prohibiting the free distribution of these products and sales through vending machines.

 

The minister will also have the authority to regulate the flavors, packaging, and display of vapes and other nicotine products, as well as the power to modify and update product standards.

 

 

Expanding existing legislation

 

 

The Tobacco and Vapes Bill will also extend existing indoor smoking restrictions to certain outdoor public spaces and workplaces. The government is considering expanding smoke-free areas to include areas outside of schools, children's playgrounds, and hospitals, but will not cover outdoor dining areas or beaches and other broader open spaces. Specific locations that should be smoke-free will be determined through secondary legislation and will undergo thorough consultation.

 

In addition, smoke-free places also prohibit vapes and heated tobacco products.

 

 

Strict law enforcement and product registration system

 

 

Furthermore, the bill will enhance enforcement efforts and support the implementation of the above measures. It will empower the introduction of a specific licensing regime for retail tobacco products, herbal smoking products, rolling papers, vapes, and nicotine products in England, Wales, and Northern Ireland. The bill also strengthens Scotland's existing retail registration, expanding it to include herbal smoking products and nicotine products.

 

It will also give enforcement agencies in England and Wales the power to issue Fixed Penalty Notices (FPNs) of up to £200 for illegal activities, including selling tobacco and vape products to minors, and £2,500 FPNs for offences in connection with licensing.

 

The government will also be given the authority to introduce a new product registration system for tobacco, vaps, and nicotine products. This system will outline requirements for producers and manufacturers before their products are sold to consumers.

 

 

Geographical scope

 

 

The bill will apply to the entire UK and will create a coordinated and consistent regulatory framework for tobacco and vape products, building on existing legislation in the four constituent countries. The UK government worked in partnership with the Scottish government, the Welsh government, and the Northern Ireland Executive to develop the bill. 

 

Under the devolution agreement, measures vary across the UK, with Wales and Scotland already making further progress in smoke-free areas, banning smoking outside hospitals. Wales has also implemented smoke-free policies outside hospitals and school grounds.

 

Subject to approval from Parliament, the age of sale restrictions for tobacco will come into force on 1 January 2027, when those born on 1 January 2009 turn 18.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | BAT Revises Japan's VELO Convenience Store Lineup, Adding ¥380 Mango Pouches as Selected SKUs Exit
Product | BAT Revises Japan's VELO Convenience Store Lineup, Adding ¥380 Mango Pouches as Selected SKUs Exit
British American Tobacco's Japanese subsidiary, BAT Japan, launched VELO Mango Ice Medium on November 2, 2026, with distribution expanding to selected 7-Eleven, FamilyMart, NewDays and Seicomart stores from November 3. The new oral tobacco product contains 15 pouches per can and retails for ¥380, featuring a mango and cooling flavor profile at Medium intensity. At the same time, BAT Japan raised prices on multiple existing VELO products from ¥360 to ¥380 per can and withdrew selected SKUs from convenience store distribution without discontinuing them entirely. The changes affect product assortment, pricing and retail channel allocation.
product
Nov.04
White House Pulls Heidi Overton's FDA Nomination as Vaccine, Abortion Pill and Vaping Disputes Fuel Senate Opposition
White House Pulls Heidi Overton's FDA Nomination as Vaccine, Abortion Pill and Vaping Disputes Fuel Senate Opposition
The White House withdrew Heidi Overton's nomination to lead the U.S. Food and Drug Administration (FDA) on November 17, 2026, a day before a scheduled Senate committee vote. Overton faced questions from Republican and Democratic senators over vaccines, abortion medication and flavored nicotine products. In May, the FDA granted its first marketing authorizations for non-tobacco, non-menthol e-cigarette flavors, including mango and blueberry pods from Glas. Republican Senator Susan Collins challenged recent authorizations for flavored vaping and nicotine pouch products during Overton's September confirmation hearing. The FDA remains under Acting Commissioner Kyle Diamantas.
FDA
Nov.18
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
A 2Firsts analysis of Virginia's liquid nicotine and vapor product certification directory identified 213 product records from 15 manufacturers. Companies associated with BAT, Altria, Imperial Brands, JTI and JUUL account for 127 entries. The directory also includes independent brands CrossBar 20K, Loon and Breeze. CrossBar advertises a 13mL disposable capable of up to 20,000 puffs, while Loon has 16 disposable entries featuring fruit, cooling and beverage-related flavors. Of all records, 120 are labeled as under FDA PMTA review. Virginia introduced revised penalties on October 1, 2026, including a minimum first-violation civil penalty of $5,000 per unlisted product, alongside new retail tobacco permitting requirements.
Regulations
Oct.30
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
SMOORE-owned vaping brand VAPORESSO introduced the VAST refillable open-system vape in October 2026, featuring Tri-Core Mesh technology that integrates three resistance configurations—0.8Ω, 0.6Ω and 0.4Ω—within a single pod. The device supports different operating modes and e-liquid types. The standard version features a 10mL pod, while a TPD-labelled configuration combines a 2mL pod with an 8mL refill container. The device has a 1,600mAh battery and a maximum output of 30W. VAPORESSO claims up to six pod refills and a tested coil lifespan of up to 150,000 puffs. The UK's MHRA published a related device notification on October 12. The official MSRP is $25.90, compared with a $35.90 listing on VAPORESSO's direct store.
product
Oct.30
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
U.S. Judge Stays Helix, NJOY Challenge to FDA PMTA Rule Pending New Rulemaking Court Stays Altria's Helix, NJOY Challenge to PMTA Rule as FDA Prepares New Rulemaking
A federal judge in Texas on Oct. 8 granted a joint request by the FDA and plaintiffs including Altria subsidiaries Helix Innovations and NJOY to stay litigation challenging the agency's 2021 PMTA rule. The court cited FDA's anticipated rulemaking concerning the regulation at issue. FDA announced on Sept. 28 that it intends to reassess the PMTA framework and could initiate new rulemaking to replace it. The parties must file a joint status report within 45 days and every 45 days thereafter. A motion by three Reynolds American companies to intervene remains pending.
Regulations
Oct.10